why is bpc-157 banned BPC-157: The Real Reason It's Not FDA Approved The Hidden Risks of BPC‑157:

Evidence Boundary Most studied route in the Phase 2 program, but the OPTIONS trial missed its primary weight-loss endpoint and development was terminated in 2007

for isolated adipocyte lipolysis research, AOD-9604 offers cleaner mechanistic specificity

intracellular half-life is prolonged because of lysosomal release and cytosolic resequestration, creating a depot effect that supports monthly maintenance dosing for chronic deficiencies

It delivers copper straight to the cells at the base of hair follicles, helping keep them alive, boosting blood vessel growth around the follicle, and calming the scarring signals that can shrink it

They are intended to complement a low-calorie diet and exercise as part of a weight loss or weight management plan

Approximately 60% of children with autism demonstrated increased HPLC peaks consistent with opioid peptides compared to controls, representing one of the largest studies suggesting peptide elevation